Whilst NICE has not yet issued specific guidance on retatrutide reflecting its investigational status existing NICE and NHS frameworks for GLP-1 receptor agonists and nutritional deficiency management provide a relevant and applicable foundation for clinical practice
Well-structured treatments lasting 6-12 months with appropriate concentrations typically maintain noticeable improvements over pre-treatment baseline including reduced fine lines (though not eliminated as during peak treatment), improved skin texture and firmness (though less dramatic than treatment peak), better overall skin quality and appearance (though aging continues at normal rates), and resolved specific issues like scarring or hyperpigmentation (which typically remain improved permanently if successfully treated)
Treatment with GLP-1 RAs was not associated with progression to PDR (1121 of 32 695 [3.4%] vs 1039 of 32 695 [3.2%] events
Even after the acne itself heals, dark spots, redness, and uneven skin texture often remain
There are several expensive brand-named products, such as Ozempic and Wygovy, currently on the market
[DOI] [PubMed] [Google Scholar] 46.Highlights of Prescribing Information